E-configuration benzamide compounds, and pharmaceutical preparation application thereof

A technology of benzamide and compounds, which is applied in the field of chemical pharmaceuticals, can solve the problems of unobtained, undisclosed, unobtainable solid dispersion of benzamide and polyvinylpyrrolidone, etc., and achieve the effect of improving dissolution rate and bioavailability

Active Publication Date: 2014-06-25
SHENZHEN CHIPSCREEN BIOSCIENCES CO LTD
View PDF3 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

According to the information disclosed in the application document CN103432077A, it is N-(2-amino-4-fluorophenyl)-4-[N-(3-pyridine) prepared according to the cited literature (US7,244,751B2) in Example 3 Acryloyl)aminomethyl]benzamide, N-(2-amino-4-fluorophenyl)-4-[N-[(E)-3-(3-pyridine)acryloyl]aminomethyl was not obtained Base] benzamide (i.e. the E-type isomer), therefore, it is impossible to obtain N-(2-amino-4-fluorophenyl)-4-[N-

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • E-configuration benzamide compounds, and pharmaceutical preparation application thereof
  • E-configuration benzamide compounds, and pharmaceutical preparation application thereof
  • E-configuration benzamide compounds, and pharmaceutical preparation application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Example 1: Preparation of 4-[N-[(E)-3-(3-pyridine)acryloyl]aminomethyl]benzoic acid

[0054]

[0055] Add 298g (2.00mol) trans-3-(3-pyridine)acrylic acid, 324g (2.00mol) N,N'-carbonyldiimidazole and 3000mL tetrahydrofuran into a 5-liter three-neck glass flask equipped with mechanical stirring and reflux condenser , react at about 45°C for about 3 hours to prepare (E)-3-(3-pyridine)acryloyl imidazole active intermediate solution.

[0056] Add 302g (2.00mol) p-aminomethylbenzoic acid, 80g (2.00mol) sodium hydroxide and 2000mL water into another 10-liter three-neck glass flask equipped with mechanical stirring, stir at room temperature for about 30 minutes, and then dropwise add the above ( E) -3-(3-pyridine) acryloyl imidazole active intermediate solution, react at room temperature for about 8 hours. Concentrate the reaction mixture in vacuo to remove tetrahydrofuran, add 2000 mL of saturated sodium chloride solution, neutralize with concentrated hydrochloric acid unt...

Embodiment 2

[0061] Example 2: Preparation of N-(2-amino-4-fluorophenyl)-4-[N-[(E)-3-(3-pyridine)acryloyl]aminomethyl]benzamide

[0062]

[0063] Add 282g (1.00mol) 4-[N-[(E)-3-(3-pyridine)acryloyl]aminomethyl]benzoic acid, 162g (1.00mol) N,N'-carbonyldiimidazole and 2820mL tetrahydrofuran were reacted at 45°C for about 3 hours to obtain 4-[N-[(E)-3-(3-pyridine)acryloyl]aminomethyl] Benzoyl active intermediate solution.

[0064]Add 168g (1.33mol) of 4-fluoro-o-phenylenediamine and 800mL of tetrahydrofuran into another 5-liter three-neck glass flask equipped with mechanical stirring, protect it with nitrogen, stir at room temperature for about 10 minutes, add the above 4-[N-[ (E)-3-(3-pyridine)acryloyl]aminomethyl]benzoyl active intermediate solution, react at room temperature for about 24 hours. Filter, rinse the filter cake with 400 mL of tetrahydrofuran, and dry in vacuo to obtain a crude product. Dissolve the crude product in 1200mL2mol / L hydrochloric acid, add dropwise 960mL1mol / ...

Embodiment 3

[0070] Example 3: Determination of the inhibitory activity of test compounds on different subtypes of HDAC

[0071] 1. Experimental plan

[0072] Utilizing 11 subtypes of purified HDAC (HDAC1-11) in class I, II, and IV, the sirtuin detection kit produced by BSP Bioscoence was used to measure the inhibitory activity of the test compound on different subtypes of HDAC, and calculated Its half inhibitory concentration of enzyme activity (IC 50 ).

[0073] 2. Experimental materials and reagents

[0074] (1) N-(2-amino-4-fluorophenyl)-4-[N-[(E)-3-(3-pyridine)acryloyl]aminomethyl]benzamide, according to the embodiment of the present invention 2 preparation, which was dissolved in DMSO (100mM).

[0075] (2) N-(2-amino-4-fluorophenyl)-4-[N-(3-pyridylacryloyl)aminomethyl]benzamide, prepared according to Example 2 of US7,244,751B2, dissolved in in DMSO (100 mM).

[0076] (3) Bovine serum albumin (1mg / mL)

[0077] (4) Purified HDAC1-11 subtype protein (0.4ng / μL, N-GST tagged, BSP B...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses E-configuration benzamide compounds, and a pharmaceutical preparation application thereof. The structure of the E-configuration benzamide compounds is disclosed as Formula (I); the chemical name is N-(2-amino-4-fluorophenyl)-4-[N-[(E)-3-(3-pyridyl)acryloyl]aminomethyl]benzamide; and in the structural formula, the configuration of the 3-pyridylacryloyl group is E. The E-configuration benzamide compounds disclosed as Formula (I) have subtype selective histone deacetylase inhibition activity, and are mainly used for inhibiting HDAC1, HDAC2 and HDAC3 in Class I HDAC and HDAC10 in Class IIb HDAC. The E-configuration benzamide compounds disclosed as Formula (I) can be used for treating diseases related to histone deacetylase activity abnormity, such as cancers, including lymphomata, entity tumor, blood system tumors and the like.

Description

technical field [0001] The invention belongs to the field of chemical pharmacy, and in particular relates to an E-configuration benzamide compound, a pharmaceutical preparation and application. Background technique [0002] Histone deacetylase (HDAC) is a class of enzymes that catalyze the removal of the acetyl group on lysine of histone, and plays a key role in chromatin condensation and chromatin remodeling and gene regulation. An important component of epigenetic regulation. HDAC includes four categories and 18 different subtypes (Class I: HDAC1, 2, 3, 8; Class II: HDAC4, 5, 6, 7, 9, 10; Class III: Sirt1-7; Class IV: HDAC11) . HDAC and histone acetyltransferase (HAT) jointly regulate the acetylation modification of histones. HAT acetylates specific lysine (Lys) residues on histones, and HDAC is responsible for removing this residue modification. Acetylation of histones relaxes the chromatin structure, which facilitates the binding of other DNA-binding proteins (such as...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D213/56A61K31/4406A61K9/14A61K9/20A61P35/00A61P35/02
CPCA61K9/1635A61K9/1641C07D213/56A61K9/146A61K9/2054A61K9/2059A61K31/4406A61P35/00A61P35/02
Inventor 鲁先平李志斌徐学奎
Owner SHENZHEN CHIPSCREEN BIOSCIENCES CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap